a maleimide in mycelium of Antrodia camphorate , inhibits progression of human MDA-MB-231 breast cancer cells

1. Department of Chemistry, National Changhua University of Education, No. 1, Jin-De Road, Changhua 500, Taiwan. 2. School of Medicine, Chung Shan Medical University, No.110, Sec.1, Jianguo N.Rd.,Taichung City 402,Taiwan. 3. Division of Colorectal surgery Department of Surgery Chung Shan Medical University Hospital, No.110, Sec.1, Jianguo N. Rd.,Taichung City 402,Taiwan. 4. Department of Pathology, Chung Shan Medical University Hospital, No.110, Sec.1, Jianguo N.Rd.,Taichung City 402,Taiwan. 5. Institute of Biochemistry and Biotechnology, college of medicine, Chung Shan Medical University, No.110, Sec.1, Jianguo N.Rd.,Taichung City 402,Taiwan. 6. School of Medical Applied Chemistry, Chung Shan Medical University, No. 110, Section 1, No.110,Sec.1,Jianguo N.Rd.,Taichung City 402,Taiwan. 7. Department of Medical Education, Chung Shan Medical University Hospital, No.110, Sec.1, Jianguo N.Rd.,Taichung City 402,Taiwan.

[1]  P. Chueh,et al.  Antrodin C Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Suppression of Smad2/3 and β-Catenin Signaling Pathways , 2015, PloS one.

[2]  Hsueh-Wei Chang,et al.  The Antitumor Activity of Antrodia camphorata in Melanoma Cells: Modulation of Wnt/β-Catenin Signaling Pathways , 2012, Evidence-based complementary and alternative medicine : eCAM.

[3]  Dar-Ren Chen,et al.  Anticancer effects of eleven triterpenoids derived from Antrodia camphorata. , 2012, Anticancer research.

[4]  T. Tseng,et al.  Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B. , 2012, European journal of pharmacology.

[5]  M. Post,et al.  Mouse Snail Is a Target Gene for HIF , 2011, Molecular Cancer Research.

[6]  Y. Tzeng,et al.  Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds , 2011, Evidence-based complementary and alternative medicine : eCAM.

[7]  Nagy Ma.  HIF-1 is the Commander of Gateways to Cancer , 2011 .

[8]  A. Levitzki,et al.  Signal transduction therapy of cancer. , 2010, Molecular aspects of medicine.

[9]  R. Goldman,et al.  Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Lee S. Rosen,et al.  Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review , 2010, The oncologist.

[11]  J. Massagué,et al.  Molecular basis of metastasis. , 2008, The New England journal of medicine.

[12]  W. Sellers,et al.  Drug discovery approaches targeting the PI3K/Akt pathway in cancer , 2008, Oncogene.

[13]  S. Karpatkin,et al.  Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis. , 2008, Cancer research.

[14]  Zhenheng Lai,et al.  Total synthesis of (±)-camphorataimides and (±)-himanimides by NaBH4/Ni(OAc)2 or Zn/AcOH stereoselective reduction , 2008 .

[15]  Z. Bhujwalla,et al.  Silencing of Cyclooxygenase-2 Inhibits Metastasis and Delays Tumor Onset of Poorly Differentiated Metastatic Breast Cancer Cells , 2007, Molecular Cancer Research.

[16]  A. Harris,et al.  Role of hypoxia-inducible factor-1alpha as a cancer therapy target. , 2006, Endocrine-related cancer.

[17]  J. Simons,et al.  Hypoxia-inducible factor-1 in human breast and prostate cancer. , 2006, Endocrine-related cancer.

[18]  Shailesh Singh,et al.  Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression , 2006, BMC Cancer.

[19]  A. Lucci,et al.  COX-2 overexpression increases motility and invasion of breast cancer cells. , 2005 .

[20]  Xavier Matias-Guiu,et al.  NF-kB in development and progression of human cancer , 2005, Virchows Archiv.

[21]  K. Reddy,et al.  Role of MAP kinase in tumor progression and invasion , 2003, Cancer and Metastasis Reviews.

[22]  M. Hendrix,et al.  Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. , 1997, The American journal of pathology.